All articles
86Stroke

2026-08-04
What Happened When Stem Cells Were Infused for Acute Ischaemic Stroke — MASTERS and the Answer 'No Difference'
1.2 billion allogeneic MAPC (MultiStem) IV 24–48 h after stroke. MASTERS (double-blind, 137 randomised, 33 UK/US sites) was safe, but the day-90 primary endpoint failed in the 126 analysed (OR 1.08, p=0.83). Plus the 9 years since.
解説を読む →
Stroke

2026-08-04
“The Primary Efficacy Endpoint Was Not Met” — What PISCES-2, Which Implanted Neural Stem Cells into the Brain, Really Left Behind
At eight UK sites, 20 million allogeneic neural stem cells (CTX0E03) were injected into the putamen of 23 stroke patients by stereotactic neurosurgery. The primary endpoint was not met, the randomized trial meant to confirm the findings stopped at 15 patients, and the developer went through administration and delisted. Here is what a single-arm study can and cannot say, read straight from the numbers.
解説を読む →
Stroke

2026-08-04
Leaving Stem Cells Behind in the Chronic Stroke Brain — SB623, Two-Year Results in 18 Patients, and the Reckoning That Came Afterward
An average of 22 months after stroke, paralysis that should no longer move. A phase 1/2a trial implanting genetically modified allogeneic bone marrow MSCs (SB623) around the infarct met its primary endpoint in 18 patients over two years. But there is no control group. Two months later the phase 2b ACTIsSIMA, sham-controlled in 163 patients, missed its primary endpoint (p = 0.6743). The same cells reached approval not in stroke but in the parallel traumatic brain injury trial.
解説を読む →
Extracellular Vesicles

2026-08-03
IL-10 Becomes Harder to Break Down When Loaded onto Extracellular Vesicles — But Naïve Vesicles, With No Gene Added, Calmed Inflammation Too
IL-10, the cytokine that calms inflammation, never quite became a drug: it is unstable and clears from the body fast. A Michigan State University team harvested extracellular vesicles from cells made to overexpress IL-10 with minicircle DNA, and shows they are more stable than recombinant IL-10 and quiet inflammatory macrophages. But naïve vesicles, with no IL-10 gene introduced, worked too. Every experiment is in cultured cells.
解説を読む →
Clinical

2026-08-01
Antibody ALMB-0166 Calms Overactive Astrocytes — Safety and Early Signals from a First-in-Human Trial in Spinal Cord Injury
ALMB-0166, the first Cx43-hemichannel antibody, given as a single dose to 24 SCI patients: adverse events matched placebo, 1200/2400mg improved scores, two reached AIS E. A small, exploratory result.
解説を読む →
Clinical

2026-08-01
Knee Joint Injections: Which One Actually Works?—From Steroids to Exosomes, Decoding 9 Treatments at the Molecular Level
A narrative review of knee injections, corticosteroids to exosomes: an RCT tying repeated triamcinolone to cartilage loss, and the evidence-maturity gap across PRP, orthobiologics, MSCs, exosomes.
解説を読む →
Neuroscience

2026-08-01
The 'Neurotrophic Factors' Linking Stroke, Traumatic Brain Injury, and Neurodegeneration — Why Drugs That Should Work Can't Reach the Brain
Stroke, TBI, and Alzheimer's/Parkinson's differ in cause but converge on the same breakdown pathways. Why don't NGF and BDNF work in humans? A Russian team reads the delivery barrier from six trials.
解説を読む →
Clinical

2026-07-27
Can the Brain Reclaim a Bladder That Won’t Move After Spinal Cord Injury? — What the Anti-RGMa Antibody Elezanumab Showed in Rats
Neurogenic bladder afflicts more than 80% of people with spinal cord injury. A careful reading of a preclinical study reporting that the anti-RGMa antibody elezanumab improved voiding function and neuroplasticity in rats. Efficacy in humans has not yet been shown.
解説を読む →
Stem Cell

2026-07-27
“Can Stem Cells Cure ALS?” — What a Phase 3 Trial That Missed Its Primary Endpoint Still Taught Us
A phase 3 trial in ALS of autologous mesenchymal stem cells induced to secrete high levels of neurotrophic factors (NurOwn). The primary endpoint was not met (33% vs 28%, OR=1.33, P=.45). The signal in the less-impaired subgroup was not statistically significant and is only hypothesis-generating, yet the CSF biomarkers showed a clear biological effect. A piece for reading expectation and reality apart.
解説を読む →
Neuroscience

2026-07-25
The Mitochondria Were Broken, Yet ATP Went Up — What Was Happening in the Spinal Cord of a Frog That Cannot Regenerate
A tadpole whose spinal cord is severed will regenerate; after metamorphosis, the same frog cannot, and its response closely resembles that of humans. In Chile, Dr. Slater and colleagues showed that on the non-regenerating side, mitochondria swell by day 6 after injury, cristae turn into vesicles, and the respiratory enzyme COX shuts down. Yet ATP did not fall — it rose. Genes for glycolysis and genes that mobilize fat were both switched on. That said, the extra ATP may simply have leaked out of damaged tissue. Dr. Exotaro reads this preclinical frog study.
解説を読む →
Neuroscience

2026-07-21
Move Your Own Hand by Thought Alone, and Feel It Touch: A 'Double Neural Bypass' Takes On Complete Spinal Cord Injury
A man paralyzed from the neck down can now move his own hand by thought alone and even feel the texture of what he grips. A team at the Feinstein Institutes for Medical Research has developed a 'double neural bypass (DNB)' that bridges the brain to the spinal cord and cortex at the same time. While the device is on, it takes over hand movement and touch (assist); through electrical-stimulation training it also drew out recovery that persists even after the device is switched off (therapy). Cracking an egg without breaking it, feeding himself, feeling a dog's fur again through a once-paralyzed wrist—Dr. Exotaro unpacks this landmark first-in-human study.
解説を読む →
Extracellular Vesicles

2026-07-20
When the obesity-stressed pancreas quietly calls the stem cells next door for backup: how miR-151 vesicles from beta cells turn mesenchymal stem cells into helpers
As obesity drags on, pancreatic beta cells multiply and work harder to hold off diabetes (beta cell compensation). A team at China Pharmaceutical University shows that in this emergency, beta cells release extracellular vesicles (sEV) loaded with miR-151 and turn nearby mesenchymal stem cells (MSC) into helpers. Freed from the KLF9 brake, the MSCs proliferate and secrete WNT to support beta cells. Dr. Exotaro unpacks this cell-and-mouse preclinical study.
解説を読む →
MSC Exosome

2026-07-19
Restoring the Aging Liver's Housekeeping: How THBS1 Carried by Umbilical Cord Stem Cell Exosomes Remodels a Fat-Laden Liver
Aging livers quietly store fat as autophagy rusts. A Shandong team shows HucMSC exosomes — THBS1 as key cargo, PPAR as a downstream pathway — ease fat, senescence and glucose problems in aged mice.
解説を読む →
Neuroscience

2026-07-12
Rewiring the Link Between "Muscle" and "Brain"—Cognitive-Motor Integration (CMI), the Key to Reclaiming Cognition Through Exercise in Neurological Disease
Exercise reaches the brain through peripheral signals—BDNF, lactate, immune and vascular messengers. But a biomarker "moving" is not the same as cognition returning. An Italian neurorehabilitation team offers an integrative model: the biological effects of exercise become clinically meaningful only when they couple to attention-demanding movement and surface as a behavior called cognitive-motor integration (CMI). Exotaro unpacks a review that surveys the differences across stroke, Parkinson's, MS, and TBI, and how to deploy VR, robots, and wearables.
解説を読む →
MSC Exosome

2026-07-12
Taking on Parkinson's Disease and the "Runaway Immune System of the Brain"—How an lncRNA Carried by Deep-Nasal Stem-Cell Exosomes Rewires Microglial Glucose Metabolism
In Parkinson's disease, the brain's immune cells—microglia—switch into a 'combat mode that guzzles sugar,' damaging neurons through inflammation. A research team in Haikou, China, showed that lncA2M-AS1, a long non-coding RNA (lncRNA) carried by exosomes from olfactory mucosa-derived mesenchymal stem cells (OM-MSC), calms microglial metabolism and suppresses neuroinflammation through two switches, CFL1 and ROCK1. Exotaro walks through this preclinical study in mice and cultured cells.
解説を読む →
Extracellular Vesicles

2026-07-12
Confronting Diabetes's "Wounds That Won't Heal": Delivering Blood-Vessel-Summoning Exosomes with a Dissolving Microneedle
Diabetic wounds pit impaired angiogenesis against chronic inflammation. A team engineered bFGF-loaded, RGD-targeted M2 exosomes, delivered deep by a dissolving microneedle, to speed healing in diabetic mice.
解説を読む →
Extracellular Vesicles

2026-07-06
Turning the "Natural Capsules" Secreted by Stem Cells into Drug Carriers: Engineering and Clinical Safety of MSC-Derived Extracellular Vesicles (EVs)
MSC-derived extracellular vesicles are biocompatible, low-immunogenicity 'natural nanocapsules.' This review maps six strategies to engineer them into drug carriers and their clinical safety data.
解説を読む →
MSC Exosome

2026-06-15
Continuous Infusion of Human MSC-Derived Exosomes (sEV) Enhances Motor Recovery in Spinal Cord Injury: How You Deliver Them Matters More Than the Total Dose
MSC-derived small extracellular vesicles (sEV) were given IV to spinal cord injury rats. At the same total dose, continuous infusion enhanced motor recovery more than daily injection.
解説を読む →
MSC Exosome

2026-01-15
Accelerating the Clinical Translation of Extracellular Vesicles (EVs): The Work of ISEV-TRA and Future Prospects
Extracellular vesicles (EVs) are key mediators of intercellular communication with broad application across biomedicine, veterinary medicine, cosmetics, agriculture, and the environment.
解説を読む →
MSC Exosome

2026-01-12
The Vicious Cycle of Prostate Cancer Bone Metastasis: Molecular Mechanisms by Which Cancerized Osteoclast-Derived Exosomes Drive Inflammatory Osteolysis and Tumor Progression
Bone metastasis of prostate cancer (PCa) markedly worsens prognosis, with a 5-year survival rate of only 30%, and features a complex mix of osteolytic and osteoblastic lesions.
解説を読む →
MSC Exosome

2026-01-10
Molecular Mechanism by Which Cortical Actin Depolymerization in 3D Culture Enhances MSC-Derived Exosome Secretion and Therapeutic Efficacy
This study aimed to elucidate, at the molecular level, the mechanism by which 3D culture of mesenchymal stem cells (MSCs) promotes secretion of extracellular vesicles (sEVs) compared with 2D culture.
解説を読む →
MSC Exosome

2026-01-07
Bispecific Exosome Therapy: An Innovative Approach to Immune Checkpoint Inhibitor-Resistant Melanoma Metastasis
This study focuses on developing an inhalable bispecific exosome-activated T cell (BEAT) system to treat metastatic melanoma resistant to immune checkpoint inhibitors (ICIs).
解説を読む →
MSC Exosome

2026-01-07
Astrocyte-Derived Exosome-Mediated Transport of Rps6 Promotes Local Translation and Synaptic Function in Alzheimer's Disease Model Neurons
This study elucidates how astrocyte-secreted exosomes (EVs) regulate local translation in neuronal axons and improve synaptic function in an experimental model of Alzheimer's disease (AD).
解説を読む →
Neuroscience

2026-01-05
The Role of Extracellular Matrix Degradation in Supporting Synaptic Plasticity During Brain Development
Using the zebrafish brain, this study reveals the crucial role that degradation of the extracellular matrix (ECM) plays in synaptic plasticity during brain development.
解説を読む →
Neuroscience

2026-01-05
GLP-1 Receptor Agonists: A New Hope for Alzheimer's Disease Treatment? Mechanisms and Clinical Significance from Multiple Perspectives
GLP-1 receptor agonists (GLP-1RA), approved for type 2 diabetes (T2D), obesity, and cardiovascular disease, are now drawing attention as potential therapies for Alzheimer's disease (AD).
解説を読む →
Cell Biology

2026-01-05
NAC: A Multifaceted Regulator of Nascent Polypeptide Chains That Senses the Ribosomal Tunnel and Controls Chaperone Function
This study reveals that the nascent polypeptide-associated complex (NAC) is a multifaceted regulator coordinating translation elongation, co-translational folding, and organelle targeting.
解説を読む →
Cell Biology

2026-01-03
Chemotherapy Remodels Cardiac Macrophages: A New Path to Cardioprotection
This study reveals that DNA-damaging chemotherapy dramatically alters the composition and function of cardiac-resident macrophages, with monocyte-derived macrophages conferring cardioprotection.
解説を読む →
Research Note

2026-01-03
[Research Note] Network Analysis of 5 Key miRNAs Controlling Macrophages and Their "Converging Target Proteins"
In macrophage (RAW264.7, THP-1, Kupffer cell) phenotype control, which proteins do specific miRNAs target, and what fate (inflammation, M1/M2 polarization, pyroptosis) do they ultimately drive?
解説を読む →
Cell Biology

2026-01-03
Microglial TGFβ signaling in the spinal dorsal column maintains resilience to age-associated myelin degeneration
TGFβ signaling mediates microglial resilience to spatiotemporally restricted myelin degeneration, published in Nature Neuroscience.
解説を読む →
Cell Biology

2026-01-03
Blood Biomarkers of Multimorbidity: Probing the Mechanisms of Aging Through Shared and Specific Features
This study identifies blood biomarkers of multimorbidity in older adults and clarifies their shared and specific features, linking 54 biomarkers to multimorbidity indicators in two cohorts.
解説を読む →
Cell Biology

2026-01-02
A Newcomer Macrophage Hiding in Exocrine Glands, the "Adenophage": How ILC2s and GM-CSF Weave the Secret of Maintaining Tissue Function
This study reveals a previously unknown macrophage population, the "adenophages," in exocrine glands such as the salivary glands, maintained by GM-CSF from group 2 innate lymphoid cells (ILC2s).
解説を読む →
Cell Biology

2026-01-01
Stop the Cell's "Rusting Death"! How Ferroptosis Inhibitors Open a New Frontier in Treating Intractable Diseases
Why does this research matter? Our bodies are made up of tens of trillions of cells. At the end of their lifespan or when infected, these cells carry a built-in mechanism to end their own lives.
解説を読む →
Stem Cell

2025-12-22
The Future of Testicular Cancer Treatment: A New Strategy in Which Immune Cells and Stem Cells Break Through Refractory Cancer
Testicular cancer mainly arises in men aged 15 to 35 and is regarded as one of the most curable solid tumors. But this review tackles refractory forms using cell therapy.
解説を読む →
Extracellular Vesicles

2025-12-22
The Secret of Steering the Brain's Regeneration Factory: How L-Myc and the Cell's Courier Service (EVs) Unlock the Diversity of Neural Stem Cells
The brain barely regenerates after injury. Using single-cell analysis, this work reveals how the gene L-Myc and extracellular vesicles (EVs) drive the diversity of neural stem cells.
解説を読む →
MSC Exosome

2025-12-21
Hope for Liver Cancer Treatment? The Remarkable Power of Umbilical Cord Stem Cells
A new treatment is anticipated for hepatocellular carcinoma (HCC), one of the most refractory cancers: cell therapy using umbilical cord-derived mesenchymal stem cells (UC-MSCs).
解説を読む →
MSC Exosome

2025-12-21
Toward the dream of skin regeneration! The future of wound treatment opened up by stem cells and exosomes
Treating refractory wounds and severe burns is a major challenge in modern medicine. This paper reviews the potential of mesenchymal stem cells (MSCs) and their exosomes for skin regeneration.
解説を読む →
MSC Exosome

2025-12-21
The Power of Dental Stem Cells! The Potential of "Exosomes" to Heal Spinal Cord Injury
Spinal cord injury (SCI) leaves severe sequelae, but a groundbreaking treatment has now been proposed: therapy using tiny capsules called exosomes (DPSC-Exos) secreted by dental stem cells (DPSC).
解説を読む →
MSC Exosome

2025-12-21
A Future Drug to Protect the Brain: How iPSC-Derived Extracellular Vesicles Prevent the Overwork Death of Neurons
How extracellular vesicles (EVs) from iPSC-derived glial progenitor cells protect neurons from glutamate excitotoxicity by stabilizing calcium oscillations and mitochondria.
解説を読む →
Cell Biology

2024-08-18
TLR4 Knockout Modulates Cytokine and Extracellular Matrix Expression in Chronic Spinal Cord Injury, Improving Secondary Damage and Functional Recovery
Q&A on a study showing TLR4 deficiency suppresses necroptosis (RIPK3/MLKL) and NFκB signaling after spinal cord injury (SCI), cutting chronic inflammation and aiding recovery.
解説を読む →
Cell Biology

2024-08-17
Single-cell analysis of innate spinal cord regeneration: a study using a zebrafish transection model
Single-nucleus RNA sequencing of adult zebrafish over six weeks reveals how neurogenesis and neuronal plasticity cooperate to drive spinal cord repair, identifying injury-responsive iNeurons.
解説を読む →
Cell Biology

2024-08-17
Investigating MSC (mesenchymal stem cell) Potency Metrics by Integrating Imaging Modalities with Lipidomic Analysis
A single-cell study integrating morphological and lipidomic profiling of MSCs, showing these features can distinguish functional subpopulations induced by immune stimulation.
解説を読む →
Stroke

2024-08-15
[Articles] Collateral-based selection for endovascular treatment of acute ischaemic stroke in the late window (MR CLEAN-LATE): 2-year follow-up of a phase 3, multicentre, open-label, randomised controlled trial in the Netherlands
Collateral-based selection for endovascular treatment of acute ischaemic stroke in the late window (MR CLEAN-LATE): 2-year follow-up of a phase 3 randomised trial in the Netherlands.
解説を読む →
Uncategorized

2024-08-15
Lipid-associated macrophages for osimertinib resistance and leptomeningeal metastases in NSCLC
Single-cell RNA sequencing of cerebrospinal fluid reveals lipid-associated macrophages (RNASE1_M) linked to osimertinib resistance and leptomeningeal metastases in NSCLC.
解説を読む →
Cell Biology

2024-08-15
Non-classical monocytes have the support of the whole vascular tree
Non-classical monocytes are supported by the entire vascular tree. Non-classical monocytes have the support of the whole vascular tree – Nature Reviews I
解説を読む →
MSC Exosome

2024-02-17
Comparative Evaluation of Storage Conditions for Extracellular Vesicles: Impact on Function and Therapeutic Applications
Here is the paper we introduce this time: a comparative evaluation of storage conditions for extracellular vesicles, examining how the storage state affects their therapeutic efficacy.
解説を読む →
MSC Exosome

2023-10-31
The Truth About Exosome Products: Efficacy, Safety, and a Look to the Future
Today I want to talk about the exosome infusion therapy that has become a hot topic. Let me say this first: I feel that treatments using exosomes/extracellular vesicles hold enormous promise.
解説を読む →
Clinical

2023-10-30
TAVR (Transcatheter Aortic Valve Replacement): An Innovative Advance in Heart Disease Treatment
Hello, and welcome to everyone interested in the latest advances in heart disease treatment! Today we focus on an innovative surgical technique called TAVR (Transcatheter Aortic Valve Replacement).
解説を読む →
Clinical

2023-10-27
What Is ATTR Cardiac Amyloidosis? A Thorough Explanation of the Efficacy and Safety of the Latest Treatment, Patisiran — From the Results of the NEJM APOLLO-B Trial
Heart health greatly affects our quality of life, but a progressive disease called ATTR cardiac amyloidosis threatens it. This article explains the basics of ATTR amyloidosis and focuses on Patisiran.
解説を読む →
Latest Papers

2023-10-22
Cutting-Edge Neuroscience: Dissecting the Mouse Prefrontal Cortex
Neuroscience evolves daily, with new techniques emerging to unravel the brain's mysteries. Here we introduce an innovative study on the mouse prefrontal cortex and explain its findings.
解説を読む →
Cell Biology

2023-10-13
Flow Cytometry Analysis: Constraints and Caveats of Isolating Cells from In Vivo Samples
Flow cytometry is a popular technique for analyzing cell characteristics and function, especially when cells come directly from in vivo samples. However, this approach comes with several constraints.
解説を読む →
Latest Papers

2023-10-10
New Hope for Alzheimer's Disease: Exploring the VCAM1–ApoE Pathway and Advanced Protein Interaction Tools
Alzheimer's disease is a serious challenge affecting many lives. However, recent research is opening new therapeutic avenues. This article explains the latest study on the VCAM1–ApoE pathway.
解説を読む →
Latest Papers

2023-10-08
Spatial single-cell mass spectrometry defines zonation of the hepatocyte proteome
A new spatial single-cell mass spectrometry approach characterizes the zonation of the hepatocyte proteome. This article explains the study's main findings and its applications.
解説を読む →
Cell Biology

2023-10-07
The Difference Between the Endosomal Recycling Pathway and Autophagy
The endosomal recycling pathway and autophagy are two distinct cellular processes that provide different mechanisms for maintaining cellular homeostasis. Their main differences are explained below.
解説を読む →
Latest Papers

2023-10-05
Large-scale plasma proteomics comparisons through genetics and disease associations
Using a high-throughput proteomics platform measuring thousands of plasma proteins, this study combined genetic and phenotypic data to explore bridging the gap between genome and disease.
解説を読む →
Cell Biology

2023-09-28
Pathways Related to Autophagy in Microglia
Autophagy plays a role second only to the ubiquitin-proteasome system in cellular degradation, delivering unwanted or harmful material to the lysosome for breakdown.
解説を読む →
Cell Biology

2023-09-21
What Is Fibronectin?
After spinal cord injury, scar tissue forms at the injury site. It is composed of a glial component and a fibrin component. The glial scar is characterized by extensive astrocyte proliferation.
解説を読む →
Cell Biology

2023-09-20
What Is Autophagy?
Autophagy is the process by which cells degrade and recycle damaged or dysfunctional components and unwanted proteins. It supports cellular homeostasis and is linked to disease and aging.
解説を読む →
Cell Biology

2023-09-20
What Is Microautophagy
Microautophagy is a cellular self-digestion process that degrades and recycles cellular components directly through the lysosomal membrane. Here we explain its mechanisms and roles.
解説を読む →
Cell Biology

2023-07-18
How is the P-value calculated in IPA pathway analysis?
In IPA (Ingenuity Pathway Analysis), the P-value is obtained through statistical analysis. It is a metric that evaluates whether observed data is statistically significant versus random conditions.
解説を読む →
Cell Biology

2023-07-02
What Is the Fourier Transform?
You may have heard the term "Fourier transform" in math or engineering. It is a mathematical method widely used in signal processing, image analysis, and data compression. But what exactly is it?
解説を読む →
MSC Exosome

2023-06-19
A New Possibility for Improving Body Growth and Motor Function After Spinal Cord Injury: Intervention with Extracellular Vesicles (Exosomes) Derived from Bone Marrow Mesenchymal Stem Cells
Research verifying the therapeutic effects of extracellular vesicles (exosomes) derived from bone marrow mesenchymal stem cells, with a view to future clinical application to various diseases.
解説を読む →
MSC Exosome

2023-06-08
Are MSC-Exosomes Attacked by Immune Cells?
When using extracellular vesicles (EVs) therapeutically, immune rejection must be considered. It is always a concern in cell transplantation, and in allogeneic transplants it threatens engraftment.
解説を読む →
Cell Biology

2023-06-01
What Is CRISPR Library Screening?
About CRISPR — What is CRISPR? If you are exploring the fascinating world of genetics and biotechnology, you have probably heard the term CRISPR. But what does it mean?
解説を読む →
Cell Biology

2023-06-01
Understanding the Z-Score in Biology
The use of statistical tools is widespread across many fields, including biology. One such important statistical metric is the Z-score.
解説を読む →
MSC Exosome

2023-05-30
About ESCRT in Exosome/EV Release
An explanation of the ESCRT (endosomal sorting complexes required for transport) proteins involved in the release of extracellular vesicles (EVs).
解説を読む →
Cell Biology

2023-05-30
What Is an Endosome?
An endosome is a small membranous vesicle in the cytoplasm of eukaryotic cells. It acts as an intermediate in the cell's transport system, sorting and recycling internalized substances.
解説を読む →
MSC Exosome

2023-05-28
The system that loads RNA into EVs (exosomes)
microRNA (miRNA) is a small non-coding RNA that plays a key role in the post-transcriptional regulation of genes, influencing various physiological processes and diseases.
解説を読む →
MSC Exosome

2023-05-27
How extracellular vesicles (EV) are secreted.
What a beautiful video.
解説を読む →
MSC Exosome

2023-05-26
Tangential Flow Filtration
Tangential Flow Filtration (TFF) is a filtration process in which the fluid flows along the membrane surface, unlike conventional filtration where the liquid passes straight through.
解説を読む →
MSC Exosome

2023-05-26
What Is EXODUS, the Automated EV Recovery Device
EXODUS is a device for isolating and purifying extracellular vesicles (EVs). It uses a vibrating motor to generate acoustic streaming, preventing membrane clogging and improving recovery efficiency.
解説を読む →
MSC Exosome

2023-05-21
The Relationship Between Lipid Flipping and EVs
"Lipid flipping" refers to the movement of lipid molecules from one leaflet (half) of a biological membrane to the other. This process is also called "flip-flop" or transmembrane movement.
解説を読む →
MSC Exosome

2023-05-19
ISEV2023
I'm in Seattle for ISEV2023, the international conference on extracellular vesicles (EV). Maybe because it was founded less than ten years ago, the energy is incredible and the field feels alive.
解説を読む →
MSC Exosome

2023-05-14
Exosome Biogenesis in the Endoplasmic Reticulum and Golgi Apparatus
The cellular structures behind exosome production: endoplasmic reticulum (ER), ribosomes, and Golgi apparatus, and how the endosome, multivesicular body (MVB), and microRNA (miRNA) form exosomes.
解説を読む →
MSC Exosome

2023-05-10
Biological Properties of Extracellular Vesicles
Extracellular vesicles (EVs) are tiny membrane-bound particles released by cells, attracting attention in recent years. They are highly diverse in size, origin, contents, and function.
解説を読む →
MSC Exosome

2023-05-09
An Overview of Extracellular Vesicle Science — A Brief Summary
Definition and classification of extracellular vesicles. EVs are nanosized vesicles released from cells, with membrane structures ranging from 30 nm to 1000 nm in diameter.
解説を読む →
MSC Exosome

2023-05-09
Classification of Extracellular Vesicles
Extracellular vesicles are tiny sac-like structures secreted by cells, and several subtypes exist, distinguished by size, biological properties, biogenesis mechanism, and function.
解説を読む →
Latest Papers

2023-05-08
Spinal Cord Injury: Does the Immune Response Differ by Age!?
The paper introduced today is the following. First, Salvador, A.F.M., et al., 2023. Age-dependent immune and lymphatic responses after spinal cord injury. Neuron.
解説を読む →
Stem Cell

2023-05-08
Stem Cell Clinical Science: Introduction.
Stem cell research has produced revolutionary results in biology and medicine. This website aims to provide a comprehensive understanding of stem cell clinical science.
解説を読む →
MSC Exosome

2023-05-08
Introduction: A Prologue to Extracellular Vesicle Science
This website aims to be the most detailed and comprehensive resource in the world, covering everything from the fundamentals of extracellular vesicle science to the latest research findings.
解説を読む →
MSC Exosome

2023-04-30
MitoEVs: What are mitochondria-derived extracellular vesicles?
Here is the paper introduced today. MitoEVs: A new player in multiple disease pathology and treatment. Xiyue Zhou, Shuyun Liu, et al.
解説を読む →
Stem Cell

2023-04-30
An Overview of Stem Cell Therapy in Japan: Current Status, Risks, and Future Prospects
Stem cell therapy is attracting attention as a treatment that may broaden the options for diseases that previously had none. The influence of iPS Nobel laureate Dr. Shinya Yamanaka is significant.
解説を読む →
Latest Papers

2023-04-27
A paper showing that microglia influence neuronal autophagy
The paper introduced this time is here. Microglial-to-neuronal CCR5 signaling regulates autophagy in neurodegeneration B. P. Festa, F.
解説を読む →
Clinical

2023-04-25
A new treatment for hemophilia: from the Lancet
The paper introduced here is the following. Efficacy and safety of fitusiran prophylaxis in people with haemophilia A or haemophilia B with
解説を読む →
MSC Exosome

2023-04-24
The Effect of Exosomes on Spinal Cord Injury
Exosome therapy is one of the promising novel treatments of the future, but it is currently still at the research stage. Only after efficacy is confirmed will it be offered as insured care.
解説を読む →
AI Tools

2023-04-23
Talking with papers!? An introduction to AI tools
My first post has nothing to do with regenerative medicine or stem cells, sorry. Lately I've been hooked on AI tools, and this service is unexpectedly fun, letting you dig deeper into papers.
解説を読む →
Latest Papers

2023-04-23
The primary motor cortex does not govern movement alone!?
A very interesting paper has been published in Nature. In short, the motor homunculus brain map is not as simple as reality; the cortex also coordinates with other important networks.
解説を読む →